Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 32.09 CNY -5.34% Market Closed
Market Cap: 24.7B CNY
Have any thoughts about
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Write Note

Relative Value

The Relative Value of one Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock under the Base Case scenario is 48.81 CNY. Compared to the current market price of 32.09 CNY, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
48.81 CNY
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
22
vs Industry
36
Median 3Y
3.1
Median 5Y
2.7
Industry
2.5
Forward
2.8
vs History
17
vs Industry
17
Median 3Y
26.1
Median 5Y
24.1
Industry
21.9
Forward
21
vs History
58
vs Industry
6
Median 3Y
33
Median 5Y
27.7
Industry
16.5
vs History
85
vs Industry
6
Median 3Y
27.7
Median 5Y
29.9
Industry
23.6
vs History
15
vs Industry
19
Median 3Y
3.6
Median 5Y
3.1
Industry
2.1
vs History
25
vs Industry
36
Median 3Y
2.9
Median 5Y
2.5
Industry
2.6
Forward
2.6
vs History
30
vs Industry
29
Median 3Y
6.6
Median 5Y
6.3
Industry
5.2
vs History
31
vs Industry
10
Median 3Y
30.2
Median 5Y
26.9
Industry
13.3
Forward
15
vs History
31
vs Industry
13
Median 3Y
30.2
Median 5Y
26.9
Industry
16.6
Forward
21
vs History
53
vs Industry
6
Median 3Y
30.6
Median 5Y
25.3
Industry
15.6
vs History
79
vs Industry
5
Median 3Y
39.2
Median 5Y
34
Industry
19.1
vs History
31
vs Industry
24
Median 3Y
3
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
24.7B CNY 3.1 26.8 28.7 28.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top